| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2024-04-17 | PERCEPTIVE ADVISORS LLC | VBI Vaccines Inc/BC | 1,261,710 | 4.4% | EDGAR |
| SC 13D/A | 2023-11-20 | PERCEPTIVE ADVISORS LLC | VBI Vaccines Inc/BC | 1,381,355 | 5.8% | EDGAR |
| SC 13G | 2023-07-20 | Brii Biosciences Ltd | VBI Vaccines Inc/BC | 2,131,447 | 10.0% | EDGAR |
| SC 13D/A | 2023-04-07 | PERCEPTIVE ADVISORS LLC | VBI Vaccines Inc/BC | 43,509,553 | 16.7% | EDGAR |
| SC 13G | 2023-04-06 | BlackRock Inc. | VBI Vaccines Inc/BC | 12,781,090 | 4.9% | EDGAR |
| SC 13G/A | 2023-02-01 | BlackRock Inc. | VBI Vaccines Inc/BC | 13,359,775 | 5.2% | EDGAR |
| SC 13G/A | 2022-02-10 | STATE STREET CORP | VBI Vaccines Inc/BC | - | 4.8% | EDGAR |
| SC 13G/A | 2022-02-01 | BlackRock Inc. | VBI Vaccines Inc/BC | 13,269,221 | 5.2% | EDGAR |
| SC 13G | 2021-02-11 | STATE STREET CORP | VBI Vaccines Inc/BC | - | 9.2% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | VBI Vaccines Inc/BC | 13,175,944 | 5.4% | EDGAR |
| SC 13G/A | 2020-06-09 | BlackRock Inc. | VBI Vaccines Inc/BC | 11,147,480 | 4.8% | EDGAR |
| SC 13D/A | 2020-04-28 | PERCEPTIVE ADVISORS LLC | VBI Vaccines Inc/BC | 57,111,289 | 25.3% | EDGAR |
| SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | VBI Vaccines Inc/BC | 0 | 0.0% | EDGAR |
| SC 13G | 2020-02-07 | BlackRock Inc. | VBI Vaccines Inc/BC | 10,337,329 | 5.8% | EDGAR |
| SC 13D/A | 2019-10-10 | ARCH VENTURE FUND VI LP | VBI Vaccines Inc/BC | 13,026,057 | 7.3% | EDGAR |
| SC 13D/A | 2019-09-30 | Opko Health, Inc. | VBI Vaccines Inc/BC | 6,678,751 | 3.7% | EDGAR |
| SC 13D/A | 2019-09-26 | PERCEPTIVE ADVISORS LLC | VBI Vaccines Inc/BC | 48,020,380 | 26.6% | EDGAR |
| SC 13D/A | 2019-06-20 | PERCEPTIVE ADVISORS LLC | VBI Vaccines Inc/BC | 28,020,380 | 28.1% | EDGAR |
| SC 13D | 2019-06-12 | Opko Health, Inc. | VBI Vaccines Inc/BC | 6,678,751 | 6.8% | EDGAR |
| SC 13D/A | 2019-03-13 | Opko Health, Inc. | VBI Vaccines Inc/BC | 6,678,751 | 6.8% | EDGAR |